Clinical Trials Logo

Clinical Trial Summary

Pathological out-of-control behavior is the core clinical symptom of Bulimia nervosa (BN). The study of its neural circuits and biological mechanism is very important to explore new intervention targets. Previous studies have found that the patients with BN have inhibitory control impairment, which may be the basis of uncontrolled binge eating and purging behaviors of BN. The study found that the cognitive decision-making dysfunction of substance addicts may lead to behavior solidification. At present, there is no related research on the cognitive decision-making model of BN. Previous studies of applicants have found that there is an enhancement in goal-oriented decision-making in BN, which may explain the binge eating and purging behaviors aimed at weight control. In addition, BN patients have obvious impulsiveness, and the individuals of BN often feel unable to control eating behavior , and experience obvious sense of out of control. The previous study confirmed that untreated BN patients were highly impulsive and had inhibitory control disorders. Inhibition and control disorder is one of the important pathogenesis of BN. Previous studies indicated that dorsolateral prefrontal cortex (DLPFC) and dorsomedial prefrontal cortex (DMPFC) were associated with aboved symptoms. In this study, the patients with BN were selected as subjects. A randomized, single-blind cohort study was designed to observe the effect of iTBS intervention of DLPFC or DMPFC on pathological out-of-control behavior. Combined with behavioral, neuroimaging and genetic techniques, the investigators focused on the function of the prefrontal lobe-striatum neural circuits dopamine system. By the objective markers of peripheral, brain imaging and behavior of BN, to provide new targets and ideas for the treatment of BN.

Clinical Trial Description

Bulimia nervosa(BN) is a chronic and refractory mental disorder characteristic of recurrent binge eating and weight control which mostly occur in adolescents and young women. The life-time prevalence ranges from 1.0%-4.2%, and keep increasing. Pathological out-of-control behavior is the core clinical symptom of BN. Impulsive personality trait is an important risk factor for overeating symptoms in patients with BN. Inhibition control dysfunction leads to increased impulsiveness, while impaired goal-oriented control leads to rigid behavior habits, such as obsessive-compulsive drug-seeking and drug use, resulting in pathological out-of-control behavior. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive, safe and non-invasive physical intervention and nerve stimulation, which can be targeted at specific brain regions or networks, providing hope for people who do not respond well to drug therapy. iTBS stimulation mode can induce long-term potentiation of behavior and neural activity (LTP). Previous studies indicated that dorsolateral prefrontal cortex (DLPFC) and dorsomedial prefrontal cortex (DMPFC) were associated with out-of-control behavior. In this study, the investigators will recruit 90 BN patients, would randomly divided into 30 DMPFC iTBS intervention group, 30 DLPFC iTBS and 30 sham-stimulation group. 20 iTBS will be given in the intervention group at DMPFC or DLPFC. To assess the eating disorder symptoms, impulsive and emotional change, clinical symptom scales, psychological scales and the behavioral experiments will be used at baseline, 4 weeks, 8 weeks, 12 weeks and16weeks, respectively. Furthermore, brain MRI will be used for BN at baseline. This study is innovative and feasible. If the expected results can be obtained, it will lay a foundation for understanding the common mechanism behind the pathological behavior of BN and provide new directions and ideas for the design of effective intervention measures. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT05186441
Study type Interventional
Source Shanghai Mental Health Center
Contact SuFang Peng, PhD
Phone 862134773552
Email [email protected]
Status Recruiting
Phase N/A
Start date July 1, 2020
Completion date June 30, 2023

See also
  Status Clinical Trial Phase
Completed NCT03247946 - The Influence of Upright Feeding Position on Pulmonary and Ear Morbidity N/A
Completed NCT03202576 - Nasogastric Tube Securement Comparison Study N/A
Completed NCT03211468 - Intervention Program to Improve Body Image and Self-Esteem Among Female Athletes. N/A
Completed NCT03759444 - Perception of Time by Individuals With Eating Disorders
Recruiting NCT03808467 - Cognitive Training for Patients With Eating Disorders N/A
Recruiting NCT03684239 - The Effect of G-CBT on the Patients With AN N/A
Completed NCT04431284 - Impact of COVID-19 Lockdown on Obesity and Eating Behaviors
Active, not recruiting NCT03987984 - Reliability and Validity of the Turkish Version of the Sensory Eating Problems Scale
Recruiting NCT03455088 - The Effect of G-DBT on the Patients With BN : A Multicenter Randomized Controlled Study N/A
Completed NCT03490786 - A Dose Escalating Study to Assess the Safety and Tolerability of GT-001 Phase 1
Active, not recruiting NCT03375853 - Computerized Response Training Obesity Treatment N/A
Recruiting NCT05053438 - Evaluating Hunger Manipulation During Feeding Intervention N/A
Active, not recruiting NCT03968705 - Longstanding Eating Disorders and Personality Disorders
Recruiting NCT05038033 - Addressing Anxiety and Stress for Healthier Eating in Teens N/A
Recruiting NCT04837989 - Effectiveness of the Diabetes Body Project Among Females With Type 1 Diabetes N/A
Completed NCT03542864 - Medical Supervised Duodenal-Enteral Feeding Treatment N/A